Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-030406
Filing Date
2025-02-20
Accepted
2025-02-20 12:18:54
Documents
6
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 6-K d923272d6k.htm 6-K 9182
2 EX-99.1 d923272dex991.htm EX-99.1 27968
3 EX-99.2 d923272dex992.htm EX-99.2 12655
4 GRAPHIC g923272g0220203421291.jpg GRAPHIC 1087
5 GRAPHIC g923272g1118175543097.jpg GRAPHIC 2601
6 GRAPHIC g923272g1118180011316.jpg GRAPHIC 2601
  Complete submission text file 0001193125-25-030406.txt   60156
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25644206
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)